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Purpose: This study compared the immediate effects of smoking on cardiorespiratory
responses to dynamic arm and leg exercises.
Methods: This randomized crossover study recruited 14 college students. Each
participant underwent two sets of arm-cranking (AC) and leg-cycling (LC) exercise
tests. The testing sequences of the control trial (participants refrained from smoking
for 8 h before testing) and the experimental trial (participants smoked two cigarettes
immediately before testing) were randomly chosen. We observed immediate changes
in pulmonary function and heart rate variability after smoking and before the exercise
test. The participants then underwent graded exercise tests of their arms and legs until
reaching exhaustion. We compared the peak work achieved and time to exhaustion
during the exercise tests with various cardiorespiratory indices [i.e., heart rate, oxygen
consumption (VO2), minute ventilation (VE)]. The differences between the smoking and
control trials were calculated using paired t-tests. For the exercise test periods, VO2, heart
rate, and VE values were calculated at every 10% increment of the maximal effort time.
The main effects of the time and trial, as well as their trial-by-time (4 × 10) interaction
effects on the outcome measures, were investigated using repeated measure ANOVA
with trend analysis.
Results: 5min after smoking, the participants exhibited reduced forced vital capacities
and forced expiratory volumes in the first second (P < 0.05), in addition to elevated
resting heart rates (P < 0.001). The high-frequency, low-frequency, and the total power
of the heart rate variability were also reduced (P < 0.05) at rest. For the exercise
test periods, smoking reduced the time to exhaustion (P = 0.005) and the ventilatory
threshold (P < 0.05) in the LC tests, whereas no significant effects were observed in the
AC tests. A trend analysis revealed a significant trial-by-time interaction effect for heart
rate, VO2, and VE during the graded exercise test (all P < 0.001). Lower VO2 and VE
levels were exhibited in the exercise response of the smoking trial than in those of the
control LC trials, whereas no discernable inter-trial difference was observed in the AC
Chen et al. Effects of Smoking on Arm and Leg Ergometry
trials. Moreover, the differences in heart rate and VE response between the LC and AC
exercises were significantly smaller after the participants smoked.
Conclusion: This study verified that smoking significantly decreased performance and
cardiorespiratory responses to leg exercises. However, the negative effects of smoking
on arm exercise performance were not as pronounced.
Keywords: acute effect, cigarette smoke, aerobic exercise, cardiopulmonary exercise test, cycling ergometry,
heart rate variability, pulmonary function test
INTRODUCTION
The immediate detrimental effects of cigarette smoking on
pulmonary and cardiovascular function, particularly when these
systems are stressed by the metabolic demands of exercise, have
been thoroughly investigated. The inhalation of cigarette smoke
exerts the immediate respiratory effect of increasing airway
resistance (Sobol et al., 1977; Iyawe et al., 2007). Moreover,
carbon monoxide levels in the blood increase after smoking
(Seppänen, 1977; Hawari et al., 2013). Both of these changes
reduce the amount of oxygen absorbed into the body. Several
studies have shown that cigarette smoking significantly lowers
exercise capacity, maximal oxygen consumption (VO2max), and
the anaerobic threshold. In addition, smoking’s immediate
effects have been found to increase the heart rate at rest and
to decrease the heart rate during maximal exercise (Klausen
et al., 1983; Hirsch et al., 1985; Rotstein and Sagiv, 1986).
However, the aforementioned studies have used only lower-
body exercises such as treadmill running or leg cycling (LC),
and previous studies in general have seldom focused on upper-
body exercises. The immediate effects of cigarette smoking
on arm-cranking (AC) exercise, for example, have not been
reported.
The physiologic work capacities of the upper and lower
extremities limit maximal exercise performance differently. At
any level of VO2, both the heart rate and blood pressure are
higher during arm exercise than during leg exercise (Power
and Howley, 2004). In addition, other researchers have found
that substrate oxidation during arm exercise differs from
substrate oxidation during leg exercise. Ahlborg and Jensen-
Urstad (1991) reported that dependence on plasma glucose as
an energy source is higher during AC exercise than during
LC exercise. This difference in substrate oxidation patterns
may be due to discrepancies in the distribution of muscle
fiber types. Specifically, upper-body musculature has a greater
percentage of fast-twitch fibers compared with lower-body
musculature (Johnson et al., 1973). Moreover, previous studies
have suggested that work performed by the upper body might
interfere with the normal recruitment of respiratory muscles.
Competing demands for the respiratory muscles may result
in respiratory limitations or prevent a person from properly
performing upper body exercise (Cerny and Ucer, 2004). The
present study was designed to determine the acute effect of
smoking on cardiorespiratory responses to dynamic arm and
leg exercises. We hypothesized that the negative effects of
smoking would differ significantly between these two types of
exercise.
METHODS
Participants
Sixteen moderately trained males initially volunteered to
participate in this study. Two participants failed to complete all
of the sessions because for personal reasons and were therefore
excluded from the final analysis, leaving 14 participants with a
mean age, height, weight, and body mass index were 20.4 ±
1.5 years, 171.8 ± 6.1 cm, 68.3 ± 6.2 kg, and 23.2 ± 2.7 kg/m2,
respectively. The participants had to be regular smokers and
involved in organized sports. Their mean duration of smoking
was approximately 4.0 ± 2.0 years, and the mean number
of cigarettes smoked per day was 9.9 ± 2.9. All participants
were routinely involved (6.1 ± 1.8 h/wk) in various intermittent
activities (e.g., volleyball, soccer, basketball, or softball) and
were familiar with maximal training. Medical histories were
obtained through direct interviews, and the exclusion criteria
were as follows: history of cardiovascular disease, diabetes,
or other metabolic disease known to affect the outcome
measures; respiratory disease, including asthma, and orthopedic
injury preventing the successful completion of the exercise
protocols. After a thorough explanation of the study protocol
to the participants, written informed consent was obtained. The
experimental procedure was in accordance with the Declaration
of Helsinki and was approved by the Institutional Review Board
at Chung-Hwa University of Medical Technology.
Design
This study adopted a randomized crossover design (Figure 1).
Each participant underwent 4 separate test sessions held 3–10
days apart. For two of the four test sessions, the participants were
assigned to smoke two cigarettes of a popular brand (with 10mg
of tar and 0.7mg of nicotine in each cigarette) immediately prior
to each arm and leg exercise test. For the other two test sessions,
they refrained from smoking for at least 8 h before exercising (i.e.,
the control condition). The testing sequence of the control and
experimental sessions was randomly selected. The participants
were instructed to avoid eating for 1 h, avoid caffeine for 4 h, and
avoid alcoholic beverages for 8 h before the exercise testing; they
were also instructed not to engage in strenuous exercise in the
24 h before testing. All of the test sessions were conducted in an
air-conditioned laboratory with an ambient temperature between
20 and 24◦C and a relative humidity of 50–60%.
Pulmonary Function Tests
Pulmonary function was measured using an electronic
spirometer (Vmax 29c; Sensor Medics, Yorba Linda, CA,
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FIGURE 1 | Flowchart of a randomized crossover trial of arm cranking and leg cycling tests in 14 healthy participants. Pt, participants; Random,
randomization; t1, trial 1; t2, trial 2; t3, trial 3; t4, trial 4. *Two participants discontinued the intervention because of personal reasons unrelated to the trial. These
participants were not included in the analysis.
USA) with the participant seated. Maximal inspiratory and
expiratory maneuvers were performed. Forced vital capacity
(FVC), forced expiratory volume in the first second (FEV1),
forced expiratory flow in 25-75% FVC (FEF25−75%), peak
expiratory flow (PEF), and maximum voluntary ventilation
(MVV) were determined from the best of three trials before and
after the participants smoked.
Measurement and Analysis of Heart Rate
Variability
Heart rate variability (HRV) is the physiological phenomenon of
variation in the time interval between heartbeats. It is measured
by the variation in the R–R intervals [the intervals between
R waves on the electrocardiogram (ECG)]. Electrophysiological
signals were recorded for each participant by using a miniature
physiological signal recorder (TD1; Taiwan Telemedicine Device
Company, Kaohsiung, Taiwan). To compare the effects of
smoking on HRV, the HRV of each participant was measured for
a 10-min period beginning 10min before the participant smoked
the two cigarettes and then for another 10-min period beginning
immediately after the participant smoked the two cigarettes.
The length of these periods was based on the recommendations
for HRV measures derived from short-term (≤10min) R–R
recordings (Task Force of the European Society of Cardiology
and the North American Society of Pacing (Task Force of the
European Society of Cardiology, 1996). An example of typical
R–R interval series reflecting changes in HRV is presented
in Figure 2. During the assessment period, participants were
monitored using ECG leads to record their heart rate and R–R
intervals. The raw ECG signals were recorded in real time after
analog-to-digital conversion (8-bit) at a sampling rate of 250Hz.
The R–R intervals (in milliseconds) were calculated beat-to-beat
by using a customized software program developed by Dr. Terry
B. J. Kuo (Kuo et al., 1999) (the 2nd panel of Figure 2). The R-
R values were resampled and interpolated at the rate of 7.11Hz
to accomplish the continuity in time domain. Frequency-domain
analysis was performed using the non-parametric method of fast
Fourier transform (FFT). All the signals to be analyzed were
truncated into successive 30-s epochs with 50% overlapping. A
Hamming window was applied to each time segment to attenuate
the leakage effect (Kuo and Chan, 1993; Yang et al., 2002).
For each time segment (576 s, 4096 data points), our algorithm
estimated the power spectral density based on FFT. The resulting
power spectrum was corrected for attenuation resulting from
sampling and the application of the Hamming window (Kuo
et al., 1999), and was displayed in gray scale (the 3rd panel of
Figure 2). Each component of the spectrogram was subsequently
quantified by the method of integration. For the HRV analysis,
total power (0–0.4Hz), low-frequency power (LF, 0.04–0.15Hz),
high-frequency power (HF, 0.15–0.4Hz), the ratio of low to high
frequencies (LF/HF), normalized LF (LF%), and normalized HF
(HF%) were quantified. All the parameters were logarithmically
transformed to correct for their skewed distributions (Kuo et al.,
1999). Total power is a marker of autonomic nervous activity,
HF power reflects parasympathetic nervous activity, and LF
power reflects partial contributions from both sympathetic and
Frontiers in Physiology | www.frontiersin.org 3 December 2015 | Volume 6 | Article 376
Chen et al. Effects of Smoking on Arm and Leg Ergometry
FIGURE 2 | Continuous tracing of electrocardiogram (ECG), R-R interval (RR), and power spectrogram of a participant during a transition from a
before smoking period to an after smoking period. The frequency ranges for the high-frequency (HF) and low-frequency (LF) components of RR signals are
denoted on the right side of the spectrogram. Also shown are temporal displays of integrated values for the power density values of individual spectral components.
This participant started to smoke at the 16-min time point, and the smoking process was finished at the 25-min time point. TP, total power; LF/HF, The ratio of low to
high frequencies; HF%, HF in normalized unit; LF%, LF in normalized unit.
parasympathetic nervous activity. To detect the sympathetic
effect on HRV, total power was used to normalize LF or HF
power (LF or HF%). The LF/HF was used as an index of the
sympathovagal balance (Berger et al., 1989; Task Force of the
European Society of Cardiology and the North American Society
of Pacing Task Force of the European Society of Cardiology,
1996).
Arm and Leg Exercise Testing
Participants performed graded maximal exercise tests (GXTs)
by using an ergometer (ANGIO with a reclining chair; Lode,
Groningen, TheNetherlands). The height of the ANGIO could be
adjusted electrically over a range of 140 cm, making it suitable for
both arm and leg ergometry. The testing protocol was preceded
by a 3-min accommodation period at zero load. The workload
was then increased every 2min in steps of 16W for the arms
and 25W for the legs, until exhaustion (Pate et al., 1991; Leicht
et al., 2009). The pedaling rate was maintained at approximately
50 rpm for each participant. A pedal frequency meter with visual
feedback was used by each participant to maintain the pedaling
rate. Termination occurred when the participants could not
continue because of exhaustion or when the target pedal rate
could not be maintained for 10 s despite verbal encouragement.
The end points of the graded exercise test should ideally
progress until the participant reaches a level of maximal exertion.
Therefore, all of the participants achieved at least two of the
following criteria for determining maximum capacity: (1) A
plateau in VO2 with an increased work rate; (2) a heart rate>85%
of the age-predicted maximum (220—age); (3) a respiratory
exchange ratio (RER) greater than 1.1 (Forman et al., 2010).
Metabolic Measurements and
Determination of the Ventilatory Threshold
Expired air was analyzed breath-by-breath by using an automated
system (Vmax 29c; Sensor Medics, Yorba Linda, CA, USA).
The exercise cardiorespiratory parameters were heart rate, VO2,
carbon dioxide production (VCO2), minute ventilation (VE),
RER, and the ventilatory equivalents for O2(VE/VO2) and
CO2(VE/VCO2). V-slope and ventilatory equivalence methods
were used to evaluate the ventilatory threshold (T vent) in a
combined model (Forman et al., 2010). V-slope, which is the
most common method, entails graphing VCO2 vs. VO2 values.
The T vent is identified as the point at which there is a shift in
slope along a line identified between these gas measurements.
In addition, the ventilatory equivalence method is defined as
the intensity of activity that causes the first rise in the VE/VO2
without a concurrent rise in the VE/VCO2. If the V-slope cannot
provide a reliable T vent, it is common to review the VE/VO2
and VE/VCO2 curves to determine the T vent. Two independent
evaluators with experience in exercise testing determined the T
vent values.
Data Analyses
The data are presented as the mean and standard deviation
(mean ± SD). Statistical differences before and after the
participants smoked were calculated using paired t-tests in
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the pulmonary function test and HRV analysis. In addition,
differences between the smoking and control exercise tests were
calculated using paired t-tests for the peak power, time to
exhaustion, and T vent values. However, differences in VO2, heart
rate, and ventilation variables between the smoking and control
trials during the GXTs were analyzed using trial-by-time (4× 10)
repeated-measures multivariate analysis of variance (MANOVA)
with trend analysis (Holbert et al., 1990). When necessary,
Bonferroni corrections were used for a post-hoc comparison. For
the exercise test periods, VO2, heart rate, and VE values were
calculated at every 10% increment of the maximal effort time.
A trend analysis was used to determine whether the response
patterns differed significantly for the smoking and control trials
over time. This analysis provided informative insights that
were not accessible through a traditional repeated-measures
design. Statistical analyses were conducted using PASW Statistics
Version 18.0 (SPSS Inc., Chicago, IL, USA), and the significance
level was set at P < 0.05.
RESULTS
Pulmonary function was first tested to serve as a baseline value
in the experimental session before the GXTs. The participants
were then asked to smoke two cigarettes. The second pulmonary
function test was performed 5min after the participants finished
smoking in order to detect any immediate changes. Figure 3
shows that smoking caused a significant reduction in FVC
(P = 0.003), FEV1 (P = 0.033), and PEF (P =
0.013). In addition, the resting heart rate increased significantly
immediately after the participants smoked (P < 0.001). In
the other experimental session, we observed immediate HRV
changes after the participants smoked and before they started
the GXTs. The mean R–R interval, total power, LF, and HF
decreased significantly after the participants smoked (P < 0.05)
(Table 1). However, the LF/HF ratio, HF%, and LF% did not
change significantly.
Exercise performance (including peak power and time to
exhaustion) was significantly higher on the LC test than on AC
test in both the control and smoking trials (P < 0.001) (Table 2).
In the LC test, the peak power and time to exhaustion were lower
in the smoking trial than in the control trial (P = 0.005). In the
AC test, although the peak power was lower in the smoking trial
than in the control trial (P = 0.036), there was no significant
difference in time to exhaustion (P = 0.098). In our study,
smoking exerted a greater negative effect on exercise performance
in the LC exercise test than in the AC exercise test.
Table 3 shows a comparison of the T-vent performance
between the smoking and control trials of the AC and LC exercise
tests. For the control group, the VO2 values of the AC test
(0.78 ± 0.26 L/min) was significantly lower than those of the
LC test (1.03 ± 0.25 L/min) (P = 0.009). Similar results were
obtained from the smoking trials: the VO2 values for the AC and
LC tests were 0.70 ± 0.25 and 0.87 ± 0.18 L/min, respectively,
(P = 0.029). In the AC test, no statistical difference was observed
TABLE 1 | Immediate effects of smoking on heart rate variability (n = 14).
Heart rate variability Before smoking After smoking P-value
(mean ± SD) (mean ± SD)
R-R (ms) 712.73± 93.06 622.29± 103.82 0.001
Total power [ln(ms2)] 7.59± 0.72 6.79± 1.00 0.014
LF [ln(ms2)] 7.03± 0.79 6.27± 1.08 0.026
HF [ln(ms2)] 5.25± 0.83 4.38± 1.33 0.028
LF/HF (ln ratio) 1.78± 0.55 1.89± 0.52 0.492
LF (%) 83.43± 5.83 84.30± 4.91 0.611
HF (%) 12.45± 5.00 11.83± 4.74 0.649
R-R, mean of R-R intervals; Total power, marker of autonomic nervous activity; LF, low
frequency power reflects both sympathetic and parasympathetic modulations; HF, high
frequency reflects parasympathetic activity; LF/HF (ln ratio), the ratio of LF to HF reflects
sympathovagal balance; LF%, LF in normalized unit reflects sympathetic activity; HF%,
HF in normalized unit reflects sympathetic inhibition.
FIGURE 3 | Immediate effects of smoking on pulmonary function. FVC, forced vital capacity; FEV1, forced expiratory volume in first second; FEF25−75, forced
expiratory flow in 25–75% FVC; PEF, peak expiratory flow; MVV, maximum voluntary ventilation; HR, heart rate. Each bar is expressed as the mean ± SD, (n = 14).
*P < 0.05, **P < 0.01 indicate a significant difference compared with the baseline.
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TABLE 2 | Peak exercise test results for leg and arm ergometry according to smoking with leg-arm differences.
Trial type Peak power (Watt) Time to exhaustion (min)
Arm crank (AC) Leg cycling (LC) AC vs. LC P-value Arm crank (AC) Leg cycling (LC) AC vs. LC P-value
Control (C) 77.14 ± 9.34 158.29 ± 18.40 <0.001 8.99 ± 0.95 12.11 ± 1.42 <0.001
Smoke (S) 73.14 ± 7.88 141.36 ± 17.84 <0.001 8.51 ± 1.04 10.74 ± 1.60 <0.001
C vs. S P-value 0.036 0.005 0.098 0.005
Mean ± SD, (n = 14).
TABLE 3 | Cardiorespiratory responses during leg and arm ergometry at the ventilatory threshold.
Arm cranking Leg cycling
Control Smoking P-value Control Smoking P-value
VO2 (L/min) 0.78± 0.26 0.70± 0.25 0.189 1.03± 0.25 0.87± 0.18 0.002
VE (L/min) 22.30± 6.43 21.81± 8.19 0.818 26.03± 3.90 21.40± 2.94 <0.001
Heart rate (bpm) 116.1± 17.4 127.6± 20.5 0.053 118.4± 11.1 111.9± 9.3 0.038
RER 1.01± 0.12 1.01± 0.11 1.000 0.95± 0.09 0.88± 0.10 0.048
Workload (Watt) 41.5± 13.1 42.0± 13.4 0.793 69.0± 19.5 58.4± 12.2 0.077
Mean ± SD, (n = 14).
VO2, oxygen consumption; VE , ventilation; RER, respiratory exchange ratio.
between the groups for VO2, VE, RER, and workload; however,
the smoking trials displayed a trend of increased heart rate (P =
0.053). In the LC test, although there was no statistical difference
for workload (P = 0.077), VO2 (P = 0.002), VE (P < 0.001),
heart rate (P = 0.038), and RER (P = 0.048) exhibited significant
reductions at the T vent between the smoking and control trials.
Therefore, we concluded that smoking significantly reduces the
cardiorespiratory responses of the T vent in the LC exercise,
whereas there were no obvious effects on the AC exercise.
The MANOVA comparison of the VO2 data collected during
the exercise tests resulted in a significant trial-by-time interaction
[F(27, 351) = 21.62, P < 0.001]; the intertrial difference in VO2
was also significant [F(3, 39) = 58.46, P < 0.001] (Figure 4).
However, the post-hoc analysis revealed significant differences
between the control and smoking LC trials (regression line 4 vs.
line 3 in Figure 4, mean difference = 0.15 ± 0.04, P = 0.027),
between the control AC and LC trials (line 2 vs. line 4, mean
difference=−0.46± 0.04, P < 0.001), and between the smoking
AC and LC trials (line 1 vs. line 3, mean difference=−0.33±0.03,
P < 0.001). However, no significant difference was determined
between the control and smoking AC trials (line 2 vs. line 1, mean
difference = 0.02 ± 0.03, P = 1.00). A trend analysis revealed
that, although all of the trials showed a linear increase in VO2
over time [F(9,117) = 317.94, P < 0.001], the smoking LC trial
showed a more obvious decrease in its upward slope than did the
control LC trial.
The variation in ventilation measured over time was
significant in each trial and showed a significant trial-by-time
interaction (F = 12.05, P < 0.001). The intertrial difference
in ventilation was also significant (F = 22.61, P < 0.001)
(Figure 5). The post-hoc analysis revealed significant differences
between the control and smoking LC trials (regression line 4 vs.
FIGURE 4 | Linear time trend for the multiple scatter plot of oxygen
consumption (VO2) during the graded exercise tests for each trial.
line 3 in Figure 5, mean difference = 4.82 ± 1.49, P = 0.039)
and between the control AC and LC trials (line 2 vs. line 4, mean
difference = −9.78 ± 0.88, P < 0.001); however, a significant
difference was found neither between the control and smoking
AC trials (line 2 vs. line 1, mean difference = 0.28 ± 0.96, P =
1.00) nor between the smoking AC and LC trials (line 1 vs. line
3, mean difference = −5.24 ± 1.97, P = 0.118). A trend analysis
revealed that, although all of the trials showed a linear increase
in ventilation over time (F = 324.15, P < 0.001), the smoking
LC trial showed a more obvious decrease in its upward slope
compared with the control LC trial.
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FIGURE 5 | Linear time trend for the multiple scatter plot of minute
ventilation (VE) during the graded exercise tests for each trial.
The variation in heart rate measured over time was significant
in each trial and showed a significant trial-by-time interaction
(F = 7.44, P < 0.001). The intertrial difference in heart rate
responses was also significant (F = 5.08, P = 0.005) (Figure 6A).
The post-hoc analysis revealed significant differences between
the control and smoking AC trials (regression line 2 vs. line 1,
mean difference=−8.19± 2.20, P = 0.015) and between the
control AC and LC trials (line 2 vs. line 4 in Figure 6B, mean
difference=−10.9± 3.01, P = 0.019); however, a significant
difference was found neither between the control and smoking
LC trials (line 4 vs. line 3, mean difference = 4.02 ± 2.44, P =
0.737) nor between the smoking AC and LC trials (line 1 vs. line
3 in Figure 6C, mean difference = 1.31 ± 2.99, P = 1.00). A
trend analysis revealed that, although all of the trials showed a
linear increase in heart rate over time (F = 493.31, P < 0.001),
the control LC trial showed a more pronounced upward slope
compared with the control AC trial (Figure 6B). However, the
trend of the control LC trial also showed a decrease in its upward
slope after the participants smoked, thereby eliminating any
difference between the AC and LC tests in the smoking trials
(Figure 6C).
DISCUSSION
The present study determined that smoking two cigarettes could
immediately cause a reduction in pulmonary function and an
elevated resting heart rate. It also reduced parasympathetic
regulation and the total power of HRV. These physiological
changes had varying degrees of influence on exercise
performance in the AC and LC tests. The reduction in
pulmonary function (e.g., FEV1 and PEF) was probably due
to the bronchoconstriction caused by smoking. Previous
studies have indicated that increased airway resistance can
last for 20–30min (Sterling, 1967). We also determined that
the immediate increase in heart rate at rest was a result of
smoking’s inhibition of activity in the parasympathetic nervous
system (a decrease in the HF of HRV). This result is consistent
with Hayano et al. (1990) regarding the short-term effects
of cigarette smoking on HRV. Nevertheless, Mendonca et al.
(2011) showed that smoking resulted in a decrease in vagal
activity, which was paired with a shift in sympathovagal balance
toward greater sympathetic dominance (both the LF/HF ratio
and LF% were elevated); however, in the present study, we
observed no significant change in the LF/HF ratio, LF%, or
HF%. We suggest that using cigarettes with different nicotine
content might have contributed to the inconsistent results.
However, the Task Force of the European Society of Cardiology
and the North American Society of Pacing (Task Force of
the European Society of Cardiology, 1996) have shown that,
in some conditions associated with sympathetic excitation, a
decrease in the absolute power of the LF component is typically
observed, and the resulting tachycardia is usually accompanied
by a marked reduction in total power, which is comparable
to the findings derived from the data in our study. Moreover,
the reduction in total power influenced by LF and HF power
occurred in the same direction and prevented the appreciation
of fractional energy distribution, which would explain why the
heart rate increase during exercise was flatter than expected in
the present study. This result could be caused by the total power
significantly decreasing after the participants smoked, which
would be consistent with Mendonca et al. (2011).
In the control trials of the GXTs, the peak power, time
to exhaustion, and maximal responses of the heart rate, VO2,
and VE were lower for the AC exercise test than for the
LC test. This result is consistent with previous studies (Pate
et al., 1991; Tulppo et al., 1999; Yasuda et al., 2002; Helge,
2010; Orr et al., 2013) because the arm muscle mass involved
in AC activity is small and muscular fatigue generally occurs
before the cardiorespiratory system reaches its peak (Kang et al.,
2004). The plateauing of VO2 was generally unapparent in the
AC tests. For the experimental trials during the GXTs, the
phenomenon of higher exercise performance during the LC
exercise compared with the AC exercise does not change with
smoking. However, differences in cardiorespiratory responses
between the LC and the AC exercises became smaller and
even disappeared after the participants smoked. For example,
no statistical difference was observed in VE and heart rate
between theAC and the LC exercise tests after the participants
smoked (line 1 vs. line 3 in Figures 5, 6C). Because the lower-
body musculature has a greater percentage of slow-twitch fibers
compared with the upper-body musculature (Johnson et al.,
1973), we suggest that slow-twitch fibers were more sensitive to
the negative effects of smoking. In addition, in the LC exercise
tests, time to exhaustion and the slopes of the VO2 and VE
values decreased significantly after the participants smoked. Our
results are consistent with previous studies (Klausen et al.,
1983; Hirsch et al., 1985; Rotstein and Sagiv, 1986). However,
the unique finding of the present study is that there was no
significant change between the smoking and control trials of
the AC exercise tests (Figures 4, 5). Therefore, we conclude that
smoking-induced reductions in exercise performance occur only
when cardiopulmonary systems reach their maximal capacities.
In the AC exercise tests, the upper-body musculature was
exhausted before the cardiorespiratory systems reached their
capacities.
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FIGURE 6 | Pattern of heart rate response during the graded exercise test in the arm cranking (AC) and leg cycling (LC) trials. (A) Linear time trend for
the multiple scatter plot of heart rate for each trial. (B) The difference of linear trend for the scatter plot between the control AC and LC trials (line 2 vs. line 4, P =
0.019). (C) The difference of linear trend between the smoking AC and LC trials (line 1 vs. line 3, P = 1.00).
Johnson et al. (1973) reported that the upper-body
musculature has a higher proportion of Type II fibers compared
with the lower-body musculature. According to Ahlborg and
Jensen-Urstad (1991), AC exercise induces a greater increase
in muscle glycogen use than does LC exercise at the same
percentage of VO2peak, thus resulting in a higher net lactate
release from exercising muscles. Although muscle glycogen and
lactate concentrations were not measured in the present study,
one explanation for higher carbohydrate oxidation during AC
exercise might be that the aerobic capacity of the skeletal muscles
tends to be lower in the arms because they are used less than
the legs in daily activities. In this study, we also determined the
T vent between the AC and LC exercise tests and the effect of
smoking on the T vent. Our results show that the T vent of the
control AC exercise test was lower than that of the LC exercise
test. In addition, smoking significantly reduced the T vent of
the LC exercise test but not that of the AC exercise test. These
results indirectly support the notion that the aerobic capacity
of arm skeletal muscles tends to be lower than that of the leg
muscles because of the higher proportion of Type II muscle
fibers in arm muscles. Consequently, the effect of smoking
on the T vent is more pronounced in LC than in AC exercise
tests.
Previous studies have revealed that arm exercise interferes
with the respiratory muscles. Using the arms might interfere
with inspiration by limiting the ability of the diaphragm
to descend or of the rib cage to expand (Cerny and Ucer,
2004). The maximal ventilatory capacity of AC exercises is
fundamentally limited by this factor, which contributes to a
lower ventilatory capacity in the arm musculature than in
the leg musculature and deteriorates exercise performance
in extreme AC exercises. Consequently, the arm musculature
commonly fatigues before reaching maximal cardiopulmonary
function during GXTs, causing exercise performance to
be significantly lower on the AC tests than on the LC
tests. In addition, the negative effect of smoking on the
maximal aerobic exercise test of the AC trials may have been
diluted.
This study had certain limitations. It investigated the
immediate responses of smoking on moderately trained people
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during maximal AC and LC exercise tests. The interference
caused by AC exercise on the respiratory muscles differs little
between moderately trained people and elite athletes; however,
elite athletes certainly have a higher aerobic capacity. Therefore,
we cannot determine what impact smoking has on the AC aerobic
performance of elite athletes.
CONCLUSIONS AND PRACTICAL
IMPLICATIONS
This study verifies that smoking can significantly decrease
LC exercise performance by reducing heart rate reserves (i.e.,
increased resting heart rate and decreased heart rate during
maximal exercise) and HRV activity; these factors can all affect
maximal VO2 during exercise. In addition, smoking immediately
reduces pulmonary function by decreasing FVC, FEV1, and
PEF. Consequently, maximal VE during LC exercise is reduced.
These negative effects of smoking caused significant performance
reductions in LC exercise tests. However, the effects of smoking
on AC exercises were not as pronounced.
Many people, including occupational workers, physically
challenged people, and athletes, engage in work activities that
predominantly entail using the upper or lower extremities. For
example, canoeing and wheelchair sports predominantly use
the arms, whereas bicycle racing predominantly uses the legs.
Consequently, comparing differences in the effect of smoking on
arm and leg exercises can both qualitatively and quantitatively
clarify variations in exercise capacity, the conditions for specific
activities, and sport performance.
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